14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for BLRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.654 6.61 %
R2 0.638 4.03 %
R1 0.628 2.43 %
Current price: 0.613
Support S1 0.596 -2.74 %
S2 0.586 -4.34 %
S3 0.571 -6.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.736 20.02 %
R2 0.708 15.42 %
R1 0.700 14.19 %
Current price 0.613
Support S1 0 .
S2 0 .
S3 0 .

BLRX Predictions History

3 years ago
JS predicted that BLRX for 2021-02-03 is going $3.01 (-2.90%)

3 years ago
Sindu Siva predicted that BLRX for 2021-02-03 is going

Rank:

3 years ago
Brandon Rahim predicted that BLRX for 2021-02-03 is going

Rank:

3 years ago
Fayez predicted that BLRX for 2021-02-03 is going

Rank:

3 years ago
Eran Drami predicted that BLRX for 2021-01-29 is going

Rank:

3 years ago
JS predicted that BLRX for 2021-01-20 is going $3.28 (33.88%)

3 years ago
Baltzera predicted that BLRX for 2021-01-20 is going

3 years ago
Walter Fordham predicted that BLRX for 2021-01-20 is going

Rank:

3 years ago
JS predicted that BLRX for 2020-12-22 is going $2.67 (1.91%)

3 years ago
JS predicted that BLRX for 2020-12-21 is going $2.58 (-2.27%)

Click to get the best stock tips daily for free!

About BioLineRx Ltd.

BioLineRx Ltd. BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat... BLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT